Creating immune privilege: active local suppression that benefits friends, but protects foes. VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Tumor-associated factors are enriched in lymphatic exudate compared to plasma in metastatic melanoma patients. Migratory DCs activate TGF-β to precondition naive CD8 + T cells for tissue-resident memory fate. Clonal replacement of tumor-specific T cells following PD-1 blockade. Peripheral T cell expansion predicts tumour infiltration and clinical response. PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer. Systemic dysfunction and plasticity of the immune macroenvironment in cancer models. Systemic immunity is required for effective cancer immunotherapy. Lesion-level response dynamics to programmed cell death protein (PD-1) blockade. Tumor-draining lymph nodes are pivotal in PD-1/PD-L1 checkpoint therapy. Lymph protects metastasizing melanoma cells from ferroptosis. Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice. Lymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in mice. The role of lymph node metastasis in the systemic dissemination of breast cancer. Lymphatics, lymph nodes and the immune system: barriers and gateways for cancer spread. Significance of axillary lymph node metastasis in primary breast cancer.

Shotty metastatic lymph nodes